X0206 3 2014-02-04 0 0001044378 BIOCEPT INC BIOC 0001265721 ARNOLD LYLE J C/O BIOCEPT, INC. 5810 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 SVP, Chief Scientific Officer Stock Options (right to buy) 4.62 2021-03-25 Common Stock 5952 D Stock Options (right to buy) 5.18 2023-07-31 Common Stock 22504 D Contingent right to receive Stock Options (right to buy) Common Stock 1190 D Restricted Stock Units (right to buy) 2015-08-24 Common Stock 10714 D Granted pursuant to equity incentive plan. The option became exercisable as to 25% of the shares on March 25, 2012. The remaining shares are becoming exercisable in 36 equal monthly installments over 3 years, subject to the Reporting Person's continued service with the Issuer. The option became exercisable as to 50% of the shares on July 31, 2013. The remaining shares are becoming exercisable in 24 equal monthly installments over 2 years, subject to the Reporting Person's continued service with the Issuer. Pursuant to employment agreement and subject to achievement of specific objective. To be determined at the time of achievement of specific objective. This restricted stock unit award was granted on August 8, 2013 and vested as to 50% of the units on that date. The remaining units are becoming vested in 24 equal monthly installments over 2 years, subject to the Reporting Person's continued service with the Issuer. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. /s/ William G. Kachioff, Attorney-in-Fact for Lyle J. Arnold 2014-02-04